An anti-tumor coup: TIM3 ablation activates the immune arsenal

Signal Transduct Target Ther. 2021 Sep 27;6(1):348. doi: 10.1038/s41392-021-00757-3.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cancer Vaccines / genetics
  • Cancer Vaccines / therapeutic use*
  • Dendritic Cells / immunology
  • Hepatitis A Virus Cellular Receptor 2 / antagonists & inhibitors
  • Hepatitis A Virus Cellular Receptor 2 / genetics*
  • Humans
  • Molecular Targeted Therapy*
  • Neoplasms / drug therapy*
  • Neoplasms / genetics
  • Neoplasms / immunology

Substances

  • Cancer Vaccines
  • HAVCR2 protein, human
  • Hepatitis A Virus Cellular Receptor 2